TY - JOUR
T1 - AIDS primary central nervous system lymphoma
AU - Flinn, Ian W.
AU - Ambinder, Richard F.
PY - 1996
Y1 - 1996
N2 - The incidence of primary central nervous system lymphomas is increased several 1000-fold in AIDS patients. These are B-cell malignancies consistently associated with Epstein-Barr virus. They typically occur late in the course of HIV infection and are associated with a very short median survival. The pattern of Epstein-Barr virus gene expression is indicative of severe immunocompromise. Radiographic differentiation from toxoplasmosis remains a problem. Polymerase chain reaction amplification of Epstein-Barr virus DNA in cerebrospinal fluid, 18F-fluoro-deoxyglucose-positron emission tomography scanning, and 201-thallium single-photon emission CT are all promising noninvasive or minimally invasive diagnostic procedures that may obviate the need for brain biopsy in the future. Occasional patients have long remissions after therapy but most patients die within a few months. A possible role for combined modality therapy, including combination chemotherapy, is being explored.
AB - The incidence of primary central nervous system lymphomas is increased several 1000-fold in AIDS patients. These are B-cell malignancies consistently associated with Epstein-Barr virus. They typically occur late in the course of HIV infection and are associated with a very short median survival. The pattern of Epstein-Barr virus gene expression is indicative of severe immunocompromise. Radiographic differentiation from toxoplasmosis remains a problem. Polymerase chain reaction amplification of Epstein-Barr virus DNA in cerebrospinal fluid, 18F-fluoro-deoxyglucose-positron emission tomography scanning, and 201-thallium single-photon emission CT are all promising noninvasive or minimally invasive diagnostic procedures that may obviate the need for brain biopsy in the future. Occasional patients have long remissions after therapy but most patients die within a few months. A possible role for combined modality therapy, including combination chemotherapy, is being explored.
UR - http://www.scopus.com/inward/record.url?scp=0029861918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029861918&partnerID=8YFLogxK
U2 - 10.1097/00001622-199609000-00007
DO - 10.1097/00001622-199609000-00007
M3 - Review article
C2 - 9026061
AN - SCOPUS:0029861918
SN - 1040-8746
VL - 8
SP - 373
EP - 376
JO - Current opinion in oncology
JF - Current opinion in oncology
IS - 5
ER -